STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Tangible Net Worth Ratio
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€19.00 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PQ6A book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
STARPHARMA HLDG.SP.ADR/10 Tangible Net Worth Ratio (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €19.00 Million with intangible assets of €0.00 EUR. Also explore PQ6A net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see STARPHARMA HLDG.SP.ADR/10 (PQ6A) total market value.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | €19.00 Million | €0.00 | €25.42 Million | ▲ +0.0 pp |
| 2024 | 100.0% | €28.12 Million | €0.00 | €36.81 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €34.81 Million | €0.00 | €52.09 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €48.39 Million | €0.00 | €66.17 Million | — |